Danaher Corp. (DHR) - Get Report , a science and technology company boasting more than 20 brands, told investors Tuesday, Jan. 9, at the JPMorgan Healthcare Conference in San Francisco that its fourth-quarter financials would exceed earlier guidance.

CEO Tom Joyce told investors that its core growth number for the quarter would be approximately 5%, an increase of 1.5 percentage points over earlier projections. Its earnings per share also will be above the top of the $1.12 to $1.16 range.

Danaher shares late on Tuesday were up 3.6% to $98.70. The stock has surged 22.6% over the past 12 months.

Across the company's four platforms, diagnostics, life sciences, dental and environmental and applied solutions generate $18 billion, with diagnostics posting almost a third of that total.

Joyce also updated the performance of Pall Corp., the company's provider of filtration, separation and purification solutions that remove contaminants or separate substances from a variety of solids, liquids and gases. It acquired the company for $13.8 billion in 2015. In the first year, Danaher realized $125 million in savings, and that number grew to $200 million last year. Three years after the deal was made, the savings have topped $350 million, $50 million more than projections.

Pall also has increased the number of new product launches by 50%.

Danaher has grown via an acquisition strategy, spending $19 billion on 25 deals since 2005.

Danaher is a holding in Jim Cramer's Action Alerts PLUS Charitable Trust Portfolio. Want to be alerted before Cramer and the AAP team buy or sell DHR? Learn more now.

More of What's Trending on TheStreet: